April 16th, 2013

Alemu. A., S., Kempker. R., R., Tenna. A., et al.

High Prevalence of cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia

Andama. A., O., S. den Boon. S. et al.

Prevalence and Outcomes of Cryptococcal Antigenemia in HIV-seropositive Patients Hospitalized for Suspected Tuberculosis in Uganda

Meyer. A. -C., Kendi. C., K. et al.

The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya

January 25th, 2013

McMullan BJ, Halliday C, Sorrell TC, et al.

Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory

Binnicker MJ, Jespersen DJ, Bestrom JE, Rollins LO.

Comparison of four assays for the detection of cryptococcal antigen

Hansen J, Slechta ES, Gates-Hollingsworth MA, et al.

Large Scale Eval of Immuno-Mycologics Inc (IMMY) LFA for detection of Crypto Antigen in Serum and CSF


December 20th, 2012

New Southern African Society Cryptococcal Treatment Guidelines

Cryptococcal Screening Algorithm (December 2012)

African Society for Laboratory Medicine

Meya, D.,  Boulware,D.  (2012 ). Cryptococcal Antigen Screening: Perspectives from Uganda 
Govender, N.,P (2012). Cryptococcosis: Preventing a Deadly Fungal Disease Together.
Bauman, (2012) A Simple Method to Diagnose Cryptococcosis: CrAg LFA.
Graeme, M. ( 2012).  Treatment of Cryptococcal Meningitis  

December 8th, 2012

Govender, N., P., et al. South Africa Medical Journal Editorial, Dec. 2012.

Phased Implementation of Screening for Cryptococcal Disease in South Africa

National Institute for Communicable Diseases -Monthly Surveillance Report

Laboratory Based Screening for Cryptococcal Diseases

South African National Institute for Communicable Diseases -NHLS Communiqué November 2012

Cryptococcal Screening Update


Reconsidering Cryptococcal Antigen Screening in the U.S. among persons with CD4<100 cells/mcL